A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic ... back at a three-year follow-up compared with patients whose immune systems did not ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

Th-302 is an investigational hypoxia-targeted drug for patients with advanced pancreatic cancer. The Phase 2 findings indicated that patients treated with Gemzar (Eli Lilly’s chemotherapy drug ...

Completed SON-1010 (IL12-F H AB) Monotherapy Dose Escalation in Phase 1 SB101 trial and announced topline safety data (December 2024). Closed a registered direct offering and concurrent private ...

The novel drug CT-179 ... How Healthy Stem Cells Turn Into ... treat spinal injuries once thought to be untreatable -- a new phase 1 trial has determined this approach is ...

Feb. 19, 2025 — Breast cancer incidence trends in U.S. women under 40 vary by geography and supports incorporating location information with established risk factors into risk prediction ...

Valleywise Health is currently looking for more volunteers. Officials say they have three right now, but they are looking to recruit up to 40 NICU cuddlers. 'Conclave' isn’t just a gripping ...